Evidence map›Paper›PMID 37795240›Full record

ArticleFrontiers in genetics2023

Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections.

Lana Salihefendić, Ivana Čeko, Larisa Bešić, Naida Mulahuseinović, Selma Durgut, Dino Pećar, Lejla Prnjavorac, Enis Kandić, Neven Meseldžić, Tamer Bego and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Lana SalihefendićALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Ivana ČekoALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Larisa BešićDepartment of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
Naida MulahuseinovićALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Selma DurgutALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Dino PećarALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Lejla PrnjavoracGeneral Hospital Tešanj, Tešanj, Bosnia and Herzegovina.
Enis KandićALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Neven MeseldžićDepartment of Pharmaceutical Biochemistry and Laboratory Diagnostics, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Tamer BegoDepartment of Pharmaceutical Biochemistry and Laboratory Diagnostics, Faculty of Pharmacy, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Besim PrnjavoracGeneral Hospital Tešanj, Tešanj, Bosnia and Herzegovina.
Damir MarjanovićDepartment of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
Rijad KonjhodžićALEA Genetic Center, Sarajevo, Bosnia and Herzegovina.
Adna AšićDepartment of Genetics and Bioengineering, International Burch University, Sarajevo, Bosnia and Herzegovina.
International Burch University · BAUniversity of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACE2COVID-19host geneticsIRF7SARS-CoV-2TMPRSS2

Identifiers

PMID37795240
PMCPMC10545899
OpenAlexW4386291669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.